Dual Therapy for Refractory IBD Shown to Reduce Surgery Needs
In a recent meta-analysis of almost 300 trials, researchers found a correlation between dual biologic or small molecule therapy and a reduced need of surgery in refractory IBD. Refractory IBD is simply Crohn’s or Colitis that is defined as persistent and acute and has not responded well to anti-inflammatory therapies. At Weill Cornell Medicine in … Read more